← Back to Search

Health Insurance Navigation for Colorectal Cancer Survivors (HINT-C Trial)

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who are 18-65 years of age

Patients who speak English

Must not have

Patients who are younger than 18 years of age or older than 65 years of age

Patients who are unable to give consent due to psychiatric or cognitive impairment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial assesses whether a navigation intervention called HINT can help colorectal cancer survivors with health insurance literacy and financial burden related to medical cost concerns.

Who is the study for?

This trial is for colorectal cancer survivors aged 18-65, who are 12-24 months post-treatment for stages I-III of the disease. Participants must have visited MGH in the last two years, have health insurance and speak English. They also need access to a device with internet like an iPad, computer or smartphone.

What is being tested?

The study is testing a Health Insurance Navigation Tools Program (HINT) designed to help colorectal survivors understand their health insurance better and reduce financial stress from medical costs. The program will be compared to standard information guides provided to a control group.

What are the potential side effects?

Since this trial involves an educational tool rather than medication, traditional physical side effects are not expected. However, participants may experience frustration or confusion if they find the tools difficult to use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I speak English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am younger than 18 or older than 65.

Select...

I am unable to give consent due to mental health or cognitive issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

change from baseline health insurance literacy to 5-month follow-up

feasibility and acceptability of the health insurance navigation program

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Navigation InterventionExperimental Treatment1 Intervention

The intervention will be delivered via synchronous videoconferencing (real-time delivery and communication between the navigator and the participant) by a trained patient navigator and will consist of 5, 30-minute sessions delivered every week. The navigation intervention group will also receive an online or mailed copy of the health insurance resource guide.

Group II: Enhanced Usual CareActive Control1 Intervention

Enhanced usual care will consist of an online or mailed health insurance resource guide.

0 / 4Eligibility criteria met